Raymond James Financial Inc. Takes $3.07 Million Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Raymond James Financial Inc. purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 233,657 shares of the company’s stock, valued at approximately $3,066,000. Raymond James Financial Inc. owned about 0.27% of Pediatrix Medical Group at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of MD. Proficio Capital Partners LLC purchased a new stake in Pediatrix Medical Group during the fourth quarter worth $404,000. M&T Bank Corp raised its holdings in shares of Pediatrix Medical Group by 16.2% during the fourth quarter. M&T Bank Corp now owns 99,090 shares of the company’s stock worth $1,300,000 after purchasing an additional 13,826 shares during the last quarter. Victory Capital Management Inc. lifted its position in Pediatrix Medical Group by 95.8% during the fourth quarter. Victory Capital Management Inc. now owns 76,553 shares of the company’s stock valued at $1,004,000 after purchasing an additional 37,463 shares during the period. Bailard Inc. acquired a new position in Pediatrix Medical Group during the fourth quarter valued at $161,000. Finally, Smartleaf Asset Management LLC boosted its holdings in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after purchasing an additional 6,090 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on MD shares. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group raised their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. Finally, Truist Financial boosted their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Trading Down 5.8 %

Shares of NYSE:MD opened at $14.15 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company’s 50 day moving average is $14.40 and its two-hundred day moving average is $13.65. The company has a market cap of $1.21 billion, a PE ratio of -11.79, a P/E/G ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.